Valeant gives Pershing Square a seat on its board

[March 09, 2016]  (Reuters) - Valeant Pharmaceuticals International Inc, under scrutiny for its accounting and business practices, said it had given shareholder Pershing Square Capital Management a seat on its board and added two additional directors.

Stephen Fraidin, a veteran Wall Street lawyer who is vice chairman at William Ackman's Pershing Square, has joined the board, along with Fred Eshelman and Thomas Ross, Valeant said.

Anders Lonner has stepped down as a director, the company said on Wednesday.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)

[© 2016 Thomson Reuters. All rights reserved.]

Copyright 2016 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.